Amneal Pharmaceuticals Inc (FRA:2DT)
€ 7.7 0 (0%) Market Cap: 2.45 Bil Enterprise Value: 4.93 Bil PE Ratio: 0 PB Ratio: 0 GF Score: 62/100

Amneal Pharmaceuticals Inc at Barclays Global Healthcare Conference (Virtual) Transcript

Mar 10, 2021 / 09:10PM GMT
Release Date Price: €4.94 (+5.71%)
Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

Good afternoon, everyone. My name is Balaji Prasad. I lead our specialty pharma coverage for Barclays. Thank you for dialing into the Barclays Global Healthcare Conference. So we are continuing the specialty pharma track of the conference, and I'm pleased to introduce the management of Amneal today. So we have with us Chirag and Chintu Patel, co-CEOs; and Tasos Konidaris, CFO. So Chirag, Chintu and Tasos, pleasure seeing you, and thank you for taking the time to join us today.

Chirag K. Patel
Amneal Pharmaceuticals, Inc. - Co-Founder, Co-CEO, President & Director

Thank you for having us.

Questions & Answers

Balaji V. Prasad
Barclays Bank PLC, Research Division - Director

So it's been an interesting 2020 for you. You took over the company in 2019. And I was just pulling up the chart and asked my team to look at it. So your stock is up nearly 2x since you joined, so you have been doing lots of things right.

So what is it that

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot